ESC Premium Access

Lipids and platelets

Event: ESC CONGRESS 2016
Topic: Lipids
Session type: Moderated Posters
Date: 28 August 2016
Time: 10:05 - 10:55


7 presentations in this session

Inhibition of lipopolysaccharide induced gene expression by HDL from healthy subjects and patients with acute myocardial infarction

Speaker: Assistant Professor S. Imaizumi (Fukuoka, JP)

Association of the postprandial chylomicron triglyceride/apoB index and cardiovascular events

Speaker: Doctor C. Werner (Homburg, DE)

Malondialdehyde assay in evaluation of aspirin antiplatelet effects

Speaker: Mrs L. Dannenberg (Duesseldorf, DE)

C2238 atrial natriuretic peptide molecular variant determines an increased platelet aggregation through the activation of NOX2 and the reduction of cAMP

Speaker: Assistant Professor S. Sciarretta (Rome, IT)

Impact of alirocumab on Lp(a) in individuals with and without moderate CKD

Speaker: Professor P. Toth (Baltimore, US)

Efficacy and safety of alirocumab in patients with multiple manifestations of cardiovascular disease (CVD): a post-hoc analysis of ODYSSEY program

Speaker: Professor K. Ray (London, GB)

Anacetrapib, but not evacetrapib, in spite of marked HDL-C increase impairs endothelial function in CETP-transgenic mice

Speaker: Doctor B. Simic (Zurich, CH)

7 speakers from this session

Assistant Professor Satoshi Imaizumi

Fukuoka University, Fukuoka (Japan)
0 follower

Doctor Christian Werner

Universitätsklinikum des Saarlandes - Klinik für Innere Medizin III, Homburg (Germany)
0 follower

Mrs Lisa Dannenberg

University Hospital Duesseldorf, Duesseldorf (Germany)
0 follower

Assistant Professor Sebastiano Sciarretta

Sapienza University of Rome, Rome (Italy)
0 follower

Professor Peter Toth

CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore (United States of America)
2 presentations
0 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
48 presentations
1 follower

Doctor Branko Simic

University of Zurich-Irchel, Department of Anatomy and Physiology, Cardiovascular Research, Zurich (Switzerland)
0 follower

This platform is supported by

logo Novo Nordisk